Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections

BACKGROUND: The novel coronavirus (SARS-CoV-2) shares approximately 80% whole genome sequence identity and 66% spike (S) protein identity with that of SARS-CoV. The cross-neutralization between these viruses is currently not well-defined. METHODS: Here, by using the live SARS-CoV-2 virus infection a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EBioMedicine
Auteurs principaux: Yang, Ren, Lan, Jiaming, Huang, Baoying, A, Ruhan, Lu, Mingqing, Wang, Wen, Wang, Wenling, Li, Wenhui, Deng, Yao, Wong, Gary, Tan, Wenjie
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Research paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372296/
https://ncbi.nlm.nih.gov/pubmed/32707445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102890
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires